Specification builder · Tier C

Gas chromatograph (GC) with flame ionisation detector and optional headspace sampler for residual solvents

A gas chromatograph separates volatile compounds in a heated capillary column and measures them with a flame ionisation detector (FID). In pharma QC and drug testing labs it is mainly used with a headspace sampler for residual solvents to USP <467> / ICH Q3C, and with liquid injection for DEG/EG limit tests, solvent purity and assays. Food, oil and university labs use the same system for fatty acid profiles, alcohols and teaching.

What this equipment will do

  • Samples: organic compounds that turn to vapour without breaking down, separated with a temperature-programmed oven up to 400 deg C or more and measured by FID with a wide linear range (Ph. Eur. 2.2.28, ASTM E594).
  • Samples: APIs, excipients and finished medicines in sealed headspace vials, where only the vapour above the sample is injected. (with the optional module)
  • Samples: liquids and solutions injected directly, such as solvents, glycerin, propylene glycol, sorbitol, syrups, edible-oil extracts and alcoholic products. (with the optional module)
  • Residual solvents in medicines: Class 1, 2 and 3 solvents by headspace GC-FID (USP <467> Procedures A, B and C, Ph. Eur. 2.4.24), compared with ICH Q3C limits. (with the optional module)
  • DEG/EG limit tests: diethylene glycol and ethylene glycol in glycerin, propylene glycol, sorbitol and syrups, plus solvent purity and assays of volatile raw materials, by liquid injection. (with the optional module)
  • Food and oils: fatty acid profiles (FAME) of edible oils and ghee, and alcohol and flavour volatiles, by liquid injection. (with the optional module)
  • Two columns of different polarity run together from one injection, for confirming residual-solvent peaks. (with the optional module)
  • Packed-column methods from older monographs. (with the optional module)
  • Permanent gases, water and other compounds the FID cannot see, with a thermal conductivity detector. (with the optional module)
  • Trace halogenated compounds such as organochlorine pesticides, with an electron capture detector. (with the optional module)
  • System suitability (resolution, tailing, plate count, signal-to-noise, %RSD) with pass/fail in reports (USP <621>, Ph. Eur. 2.2.46). (with the optional module)
  • Data integrity for GMP labs: user log-in, audit trail and electronic signatures (21 CFR Part 11, EU GMP Annex 11). (with the optional module)

Not covered: It cannot identify an unknown peak by its structure; confirming identity from a mass spectrum needs a GC-MS.; Non-volatile or heat-sensitive compounds (most drug assays, related substances, dissolution) need HPLC and a dissolution tester.; Water content of drugs and excipients needs a Karl Fischer titrator.; Heavy metals and elemental impurities (ICH Q3D) need ICP-MS/OES or an atomic absorption spectrometer.

8 international manufacturers checkedMarket checked 2026-1012 standards referenced

Loading the builder...

Standards this specification draws on

  • USP <467> Pharmacopoeial residual-solvent procedures (headspace GC-FID, Procedures A, B and C) that the system must be able to run.
  • ICH Q3C(R9) Sets the residual-solvent classes and limits (PDE) that results are compared against; current revision published April 2024.
  • Ph. Eur. 2.4.24 European/BP residual-solvent identification and control method, harmonised with USP <467>.
  • USP <621> Defines chromatography terms, system suitability and allowed method adjustments that the CDS must support.
  • Ph. Eur. 2.2.28 Pharmacopoeial gas chromatography chapter used by BP-based monographs in Pakistan.
  • USP <1058> Analytical instrument qualification framework (DQ/IQ/OQ/PQ) used to accept the GC and sampler.
  • ICH Q2(R2) Validation of residual-solvent and other GC methods (specificity, limits, linearity, precision).
  • 21 CFR Part 11 US FDA rule on electronic records and signatures; CDS audit trails and e-signatures are checked against it.
  • EU GMP Annex 11 EU/PIC/S GMP rule for computerised systems; applies to the CDS in GMP labs.
  • ASTM E594 Standard practice for testing flame ionisation detectors (noise, drift, sensitivity, linearity) used to compare bids and at OQ.
  • IEC 61010-1 Electrical safety standard for laboratory equipment.
  • ISO/IEC 17025:2017 Accreditation standard for testing labs; requires qualified, calibrated equipment and controlled data.

Common mistakes in tenders for this equipment

  • Copying one maker's datasheet figures (an exact FID detection limit such as 1.0 pg C/s, a 1000 Hz data rate, a 120-vial tray or a specific number of oven ramps) so only that brand complies; state the minimum the method needs with 'not less than' or 'not more than'.
  • Using a maker's trade names for backflush devices, electronic pneumatic modules, headspace sampling or software features instead of measurable performance.
  • Buying the GC without a headspace sampler, headspace vials or residual-solvent standards, so USP <467> testing cannot start for months after installation.
  • Leaving out gas supply: no regulators, traps, gas lines or generators in the bid, and no hydrogen leak detector, which creates delays and a fire risk.
  • Specifying helium carrier only, when nitrogen (or hydrogen) is accepted by USP <467> and helium is expensive and often unavailable in Pakistan.
  • Comparing FID detection limits measured with different test compounds and conditions; ask bidders to state the test conditions and verify sensitivity at OQ.
  • Accepting a 'Part 11 compliant' claim without a live demonstration of audit trail, user roles, e-signatures and protection against deleting injections.
  • Asking for DRAP medical-device registration: a gas chromatograph is laboratory equipment, so this demand only confuses bidders.
Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9